From: The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
 | n | % | mean; SD |
---|---|---|---|
Male | 78 | 76 | Â |
Female | 25 | 24 | Â |
Age | Â | Â | 33.8; 7.4 |
Maintenance Substances | |||
Treated with buprenorphine | 14 | 13.6 | Â |
Treated with methadone, out of them: | 89 | 86 | Â |
   - in fluid form | 77 | 86.5 |  |
   - in form of suppositoria | 11 | 12.4 |  |
   - in form of tablettes | 1 | 1.1 |  |
Stages of change | |||
   - precontemplation stage | 74 | 71.9 |  |
   - contemplation stage | 18 | 17.5 |  |
   - preparation stage | 3 | 2.9 |  |
   - maintenance stage | 4 | 3.9 |  |
   - action stage | 4 | 3.9 |  |
Smoking Variables | |||
Current smokers | Â | 93 | Â |
Former smokers | Â | 10 | Â |
Never smokers | - | - | - |
Number of cigarettes smoked per day, pcs | Â | Â | Â |
   - 0–10 | 16 | 15.5 |  |
   - 11–20 | 36 | 35 |  |
   - 21–30 | 38 | 37 |  |
   - >30 | 10 | 10 |  |
FTND score | Â | Â | Â |
   - 0–2 (low) |  | 17 |  |
   - 3–5 (moderate) |  | 28 |  |
   - 6–7 (strong) |  | 40 |  |
   - 8–10 (very strong). |  | 15 |  |